Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in Illinois 2026: $69 a month, plus yearly membership

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to Illinois from four of our partner programs. The lowest of the programs we track is $69 a month at Collective, plus a yearly membership, read on November 11, 2026.

Medicaid for weight loss
Not covered
Partner programs that ship here
Eden, Collective, SnagRx and CoreAge Rx
Adults with obesity
33.7% (CDC, 2025)

Compounded tirzepatide prices in Illinois

ProgramMonthly priceCheckedProgram's site
Eden logoEden$129 a monthNovember 11, 2026Check price →
Collective logoCollective$69 a month, plus yearly membershipNovember 11, 2026Check price →
SnagRx logoSnagRx$149 a month, or $119 a month paid 12 months up frontNovember 11, 2026
CoreAge Rx logoCoreAge Rx$129 a monthNovember 11, 2026

Eden, Collective, SnagRx and CoreAge Rx pay GLP Chart when you buy through our links.

What a year of compounded tirzepatide costs in Illinois

  • Eden ships to Illinois at $1,548 for 12 months.
  • Collective ships to Illinois at $1,027 for 12 months with its membership.
  • SnagRx ships to Illinois at $1,788 for 12 months, or $1,428 if Illinois buyers pay 12 months up front.
  • CoreAge Rx ships to Illinois at $1,548 for 12 months.

For compounded semaglutide, Illinois buyers pay from $59 a month at Collective, plus a yearly membership, against $69 for compounded tirzepatide in Illinois.

Does Illinois Medicaid cover Zepbound?

Illinois Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. Illinois Medicaid plans include Blue Cross Community Health Plans, Meridian Health Plan (Centene), Aetna Better Health Illinois and Molina Healthcare of Illinois. No Illinois Medicaid plan pays for compounded tirzepatide, so it is a cash purchase. Illinois Medicaid GLP-1 rules.

Obesity in Illinois

33.7% of adults in Illinois had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. That puts Illinois 0.2 points above the national rate, about 3 in 10 Illinois adults.

More for Illinois

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.